Viewing Study NCT02961257

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 6:51 PM

Ignite Modification Date: 2026-03-01 @ 4:45 PM

Study NCT ID: NCT02961257

Status: COMPLETED

Last Update Posted: 2022-05-12

First Post: 2016-08-22

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel

Sponsor: Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module